Omeros (OMER) Share-based Compensation (2010 - 2026)
Omeros recorded quarterly Share-based Compensation of $1.9 million in Q1 2026, up 9.0% quarter-over-quarter from $1.7 million in Q4 2025, and up 82.34% year-over-year from $1.0 million in Q1 2025.
Omeros' Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 82.34% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $5.6 million (down 27.86% YoY), while the FY2025 annual figure was $8.2 million, down 21.93% from the prior year.
- Share-based Compensation came in at $1.9 million for Q1 2026 at Omeros, up from $1.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $3.9 million in Q1 2022 to a low of $856000.0 in Q3 2025.
- A 5-year average of $2.5 million and a median of $2.7 million in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation slumped 67.59% in 2025 and soared 82.34% in 2026, its largest moves.
- Omeros' Share-based Compensation stood at $3.3 million in 2022, then slipped by 17.56% to $2.7 million in 2023, then retreated by 9.85% to $2.4 million in 2024, then dropped by 28.57% to $1.7 million in 2025, then grew by 9.0% to $1.9 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $1.9 million, $1.7 million, and $856000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 856,000.00 |
| Sep 30, 2025 | 856,000.00 |
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | 2.64 Mn |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 3.26 Mn |
| Dec 31, 2022 | 3.26 Mn |
| Sep 30, 2022 | 3.84 Mn |
| Sep 30, 2022 | 3.84 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 3.89 Mn |
| Mar 31, 2022 | 3.89 Mn |
| Dec 31, 2021 | 5.55 Mn |
| Dec 31, 2021 | 5.55 Mn |
| Sep 30, 2021 | 5.69 Mn |
| Sep 30, 2021 | 5.69 Mn |
| Jun 30, 2021 | 3.12 Mn |
| Jun 30, 2021 | 3.12 Mn |
| Mar 31, 2021 | 3.27 Mn |
| Mar 31, 2021 | 3.27 Mn |
| Dec 31, 2020 | 3.80 Mn |
| Dec 31, 2020 | 3.80 Mn |
| Sep 30, 2020 | 3.82 Mn |
| Sep 30, 2020 | 3.82 Mn |
| Jun 30, 2020 | 3.82 Mn |
| Jun 30, 2020 | 3.82 Mn |
| Mar 31, 2020 | 3.48 Mn |
| Mar 31, 2020 | 3.48 Mn |
| Dec 31, 2019 | 3.32 Mn |
| Dec 31, 2019 | 3.32 Mn |
| Sep 30, 2019 | 3.50 Mn |
| Sep 30, 2019 | 3.50 Mn |
| Jun 30, 2019 | 3.60 Mn |
| Jun 30, 2019 | 3.60 Mn |
| Mar 31, 2019 | 3.37 Mn |
| Mar 31, 2019 | 3.37 Mn |
| Dec 31, 2018 | 2.82 Mn |
| Dec 31, 2018 | 2.82 Mn |
| Sep 30, 2018 | 2.93 Mn |
| Sep 30, 2018 | 2.93 Mn |
| Jun 30, 2018 | 3.00 Mn |
| Jun 30, 2018 | 3.00 Mn |
| Mar 31, 2018 | 2.97 Mn |
| Mar 31, 2018 | 2.97 Mn |
| Dec 31, 2017 | 3.24 Mn |
| Dec 31, 2017 | 3.24 Mn |
| Sep 30, 2017 | 3.04 Mn |
| Sep 30, 2017 | 3.04 Mn |
| Jun 30, 2017 | 3.13 Mn |
| Jun 30, 2017 | 3.13 Mn |
| Mar 31, 2017 | 3.28 Mn |
| Mar 31, 2017 | 3.28 Mn |
| Dec 31, 2016 | 4.02 Mn |
| Dec 31, 2016 | 4.02 Mn |
| Sep 30, 2016 | 2.54 Mn |
| Sep 30, 2016 | 2.54 Mn |
| Jun 30, 2016 | 2.61 Mn |
| Jun 30, 2016 | 2.61 Mn |
| Mar 31, 2016 | 4.42 Mn |
| Mar 31, 2016 | 4.42 Mn |
| Dec 31, 2015 | 2.31 Mn |
| Dec 31, 2015 | 2.31 Mn |
| Sep 30, 2015 | 2.38 Mn |
| Sep 30, 2015 | 2.38 Mn |
| Jun 30, 2015 | 2.38 Mn |
| Jun 30, 2015 | 2.38 Mn |
| Mar 31, 2015 | 2.52 Mn |
| Mar 31, 2015 | 2.52 Mn |
| Dec 31, 2014 | 3.84 Mn |
| Dec 31, 2014 | 3.84 Mn |
| Sep 30, 2014 | 1.67 Mn |
| Sep 30, 2014 | 1.67 Mn |
| Jun 30, 2014 | 1.63 Mn |
| Jun 30, 2014 | 1.63 Mn |
| Mar 31, 2014 | 1.79 Mn |
| Mar 31, 2014 | 1.79 Mn |
| Dec 31, 2013 | 1.89 Mn |
| Dec 31, 2013 | 1.89 Mn |
| Sep 30, 2013 | 2.21 Mn |
| Sep 30, 2013 | 2.21 Mn |
| Jun 30, 2013 | 1.06 Mn |
| Jun 30, 2013 | 1.06 Mn |
| Mar 31, 2013 | 1.09 Mn |
| Mar 31, 2013 | 1.09 Mn |
| Dec 31, 2012 | 2.01 Mn |
| Dec 31, 2012 | 2.01 Mn |
| Sep 30, 2012 | 576,000.00 |
| Sep 30, 2012 | 576,000.00 |
| Jun 30, 2012 | 569,000.00 |
| Jun 30, 2012 | 569,000.00 |
| Mar 31, 2012 | 1.13 Mn |
| Mar 31, 2012 | 1.13 Mn |
| Dec 31, 2011 | 455,000.00 |
| Dec 31, 2011 | 455,000.00 |
| Sep 30, 2011 | 467,000.00 |
| Sep 30, 2011 | 467,000.00 |
| Jun 30, 2011 | 547,000.00 |
| Jun 30, 2011 | 547,000.00 |
| Mar 31, 2011 | 458,000.00 |
| Mar 31, 2011 | 458,000.00 |
| Dec 31, 2010 | 604,000.00 |
| Dec 31, 2010 | 604,000.00 |
| Sep 30, 2010 | 574,000.00 |
| Sep 30, 2010 | 574,000.00 |